These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38022228)

  • 1. Disease Outcomes of COVID-19 in Diabetic and Hypertensive Patients During the Hospital Stay.
    Abid A; Umar A; Qamar S
    Cureus; 2023 Oct; 15(10):e46943. PubMed ID: 38022228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Biochemical Markers in Invasive Ventilation of Coronavirus Disease 2019 Patients: Multinomial Regression and Survival Analysis.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Jawed R; Rafaey W; Hassan M; Rasheed U; Khan M; Khan AR
    Cureus; 2020 Aug; 12(8):e10054. PubMed ID: 32999777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes.
    Zehra T; Siddique SK; Aamir R; Mahmood A; Kiani AH; Virk ST
    Cureus; 2021 Mar; 13(3):e13720. PubMed ID: 33833931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematological Manifestations of COVID-19 and Their Prognostic Significance in an Intensive Care Unit: A Cross-Sectional Study.
    Bawiskar N; Talwar D; Acharya S; Kumar S
    Cureus; 2021 Nov; 13(11):e19887. PubMed ID: 34966605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?
    Dp I; Yadhav Ml K; Gs C
    Cureus; 2023 Mar; 15(3):e36734. PubMed ID: 37123703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of 47 Death Cases With COVID-19: A Retrospective Study at a Tertiary Center in Lahore.
    Ussaid A; Riaz B; Rafai W; Anwar S; Baig F; Saleem K; Pervaiz F; Firdous Z; Nasir SA; Iqbal F
    Cureus; 2020 Dec; 12(12):e12039. PubMed ID: 33457138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19.
    Patel SV; Pathak JM; Parikh RJ; Pandya KJ; Kothari PB; Patel A
    Cureus; 2024 Feb; 16(2):e54840. PubMed ID: 38533136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes of critically ill patients with COVID-19 in a tertiary community hospital in upstate New York.
    Lenka J; Chhabria MS; Sharma N; Tan BE; Boppana LKT; Venugopal S; Sondhi DS
    J Community Hosp Intern Med Perspect; 2020 Oct; 10(6):491-500. PubMed ID: 33194116
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Ketoacidosis and COVID-19: A Retrospective Observational Study.
    Nagdev G; Chavan G; Gadkari C; Sahu G
    Cureus; 2022 Oct; 14(10):e30895. PubMed ID: 36465737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
    DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
    Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Variants, Characteristics, and Outcomes Among COVID-19 Patients: A Case Series Analysis at a Tertiary Care Hospital in Karachi, Pakistan.
    Ahsan T; Rani B; Siddiqui R; D'Souza G; Memon R; Lutfi I; I Hasan O; Javed R; Khan F; Hassan M
    Cureus; 2021 Apr; 13(4):e14761. PubMed ID: 34084685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.